Literature DB >> 19285437

Hepatic interleukin-7 expression regulates T cell responses.

Yukihisa Sawa1, Yasunobu Arima, Hideki Ogura, Chika Kitabayashi, Jing-Jing Jiang, Toru Fukushima, Daisuke Kamimura, Toshio Hirano, Masaaki Murakami.   

Abstract

Systemic cytokine activity in response to Toll-like receptor (TLR) signaling induces the expression of various proteins in the liver after infections. Here we show that Interleukin-7 (IL-7), the production of which was thought to occur at a constant rate in vivo, was a hepatically expressed protein that directly controled T cell responses. Depletion of IL-7 expression in the liver abrogated several TLR-mediated T cell events, including enhanced CD4+ T cell and CD8+ T cell survival, augmented CD8+ T cell cytotoxic activity, and the development of experimental autoimmune encephalitis, a Th17 cell-mediated autoimmune disease. Thus, T cell responses are regulated by hepatocyte-derived IL-7, which is expressed in response to TLR signaling in vivo. We suggested that TLR-induced IL-7 expression in the liver, which is an acute-phase response, may be a good diagnostic and therapeutic target for efficient vaccine developments and for conditions characterized by TLR-mediated T cell dysregulation, including autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285437     DOI: 10.1016/j.immuni.2009.01.007

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  87 in total

1.  Differential localization of effector and memory CD8 T cell subsets in lymphoid organs during acute viral infection.

Authors:  Yong Woo Jung; Rachel L Rutishauser; Nikhil S Joshi; Ann M Haberman; Susan M Kaech
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

2.  The major isoforms of Bim contribute to distinct biological activities that govern the processes of autophagy and apoptosis in interleukin-7 dependent lymphocytes.

Authors:  Shannon M Ruppert; Wenqing Li; Ge Zhang; Adina L Carlson; Arati Limaye; Scott K Durum; Annette R Khaled
Journal:  Biochim Biophys Acta       Date:  2012-06-21

Review 3.  Induction of intestinal lymphoid tissue formation by intrinsic and extrinsic signals.

Authors:  Daniela Finke
Journal:  Semin Immunopathol       Date:  2009-06-09       Impact factor: 9.623

4.  IL-7 production in murine lymphatic endothelial cells and induction in the setting of peripheral lymphopenia.

Authors:  Corey N Miller; Dennis J Hartigan-O'Connor; Myeong Sup Lee; Grace Laidlaw; Ivo P Cornelissen; Mehrdad Matloubian; Shaun R Coughlin; Donald M McDonald; Joseph M McCune
Journal:  Int Immunol       Date:  2013-05-08       Impact factor: 4.823

5.  Drosophila Rel proteins are central regulators of a robust, multi-organ immune network.

Authors:  Nina Matova; Kathryn V Anderson
Journal:  J Cell Sci       Date:  2010-02-15       Impact factor: 5.285

6.  Empowering T helper 17 cells in autoimmunity.

Authors:  Marc Veldhoen; Benedict Seddon
Journal:  Nat Med       Date:  2010-02       Impact factor: 53.440

7.  Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.

Authors:  Jing Zhou; Jun-O Jin; Juan Du; Qing Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

8.  Naïve T cells re-distribute to the lungs of selectin ligand deficient mice.

Authors:  John R Harp; Thandi M Onami
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

9.  HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta.

Authors:  Caroline H T Hall; Rachel Kassel; Robert S Tacke; Young S Hahn
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

10.  Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations.

Authors:  Ryan M O'Connell; Alejandro B Balazs; Dinesh S Rao; Christine Kivork; Lili Yang; David Baltimore
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.